Both in Pharmaceuticals
MAIA Biotechnology vs Cingulate
Over the past year MAIA returned −6.9% and CING returned +24.2%; their daily moves had a correlation of 0.16.
MAIA −6.9% CING +24.2%Growth of $1, one year, split-adjusted
| Metric | MAIA | CING |
|---|---|---|
| Price | $1.08 | $4.72 |
| Market cap | $66.7M | $68.6M |
| Today | −1.82% | −6.16% |
| 1 month | −8.5% | −0.6% |
| 6 months | −22.3% | −5.2% |
| Year to date | −29.4% | +8.8% |
| 1 year | −12.9% | +24.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $27.6M | $23.3M |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 45.6% |
| Short % of float | 6.0% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).